WuXi Biologics (Cayman) I... (WXIBF)
OTC: WXIBF
· Real-Time Price · USD
4.20
0.35 (9.09%)
At close: Aug 21, 2025, 11:29 AM
WuXi Biologics (Cayman) Balance Sheet Statement
Financials in CNY. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Cash & Equivalents | 8.28B | 9.15B | 9.67B | 7.36B | 6.4B | 8.14B | 9B | 11.28B |
Short-Term Investments | 2.43B | 375.15M | 1.57B | 1.34B | 2.32B | 1.73B | 2.12B | 2.66B |
Long-Term Investments | -30.78M | 2.81B | 2.93B | 1.42B | 390.11M | 701.53M | 79.62M | -1.05B |
Other Long-Term Assets | 2.58B | 700.37M | 226.19M | 1.51B | 2.49B | 1.93B | 2.32B | 2.82B |
Receivables | 5.79B | 6.22B | 6.18B | 5.39B | 5.16B | 5.56B | 3.27B | 2.91B |
Inventory | 1.52B | 1.96B | 1.77B | 1.97B | 2.28B | 2.14B | 1.69B | 1.71B |
Other Current Assets | 5.47B | 2.01B | 2B | 1.82B | 2.32B | 3.09B | 3.44B | 3.42B |
Total Current Assets | 23.57B | 19.82B | 21.2B | 17.88B | 18.47B | 20.66B | 19.53B | 21.98B |
Property-Plant & Equipment | 28.44B | 30.78B | 29.94B | 28.99B | 25.92B | 21.85B | 19.76B | 17.74B |
Goodwill & Intangibles | 1.97B | 2B | 2.04B | 2.07B | 2.08B | 2.09B | 2.13B | 1.92B |
Total Long-Term Assets | 33.4B | 36.29B | 35.38B | 34.26B | 31.09B | 26.82B | 24.5B | 21.6B |
Total Assets | 56.98B | 56.11B | 56.58B | 52.14B | 49.56B | 47.47B | 44.03B | 43.58B |
Account Payables | 747.15M | 874.53M | 833.27M | 573.2M | 794.39M | 995.33M | 617.78M | 534.61M |
Deferred Revenue | n/a | n/a | 430.48M | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 2.44B | 892.6M | 576.33M | 1.16B | 1.32B | 2.35B | 2.12B | 1.16B |
Other Current Liabilities | 2.58B | 3.93B | 4.84B | 5.37B | 6.06B | 5.07B | 4.56B | 3.17B |
Total Current Liabilities | 8.62B | 6.81B | 7.64B | 8.14B | 9.32B | 9B | 8.26B | 5.44B |
Long-Term Debt | 200.9M | 1.26B | 1.57B | 1.66B | 1.46B | 531.9M | 640.51M | 2.07B |
Other Long-Term Liabilities | n/a | 1.17B | n/a | n/a | n/a | n/a | n/a | 1.25B |
Total Long-Term Liabilities | 2.88B | 4.66B | 4.92B | 4.96B | 4.03B | 3B | 3.07B | 4.56B |
Total Liabilities | 11.5B | 11.46B | 12.56B | 13.1B | 13.35B | 11.99B | 11.33B | 10B |
Total Debt | 4.94B | 4.57B | 4.56B | 5.14B | 4.42B | 4.4B | 4.3B | 4.6B |
Common Stock | 226K | 228K | 235K | 234K | 233K | 235K | 235K | 234K |
Retained Earnings | 16.36B | n/a | 13.49B | 12.78B | 11.58B | 9.69B | 7.16B | 5.61B |
Comprehensive Income | n/a | n/a | 1.78B | 37.74B | 1.37B | 712.48M | 593.13M | 633.19M |
Shareholders Equity | 41.82B | 40.66B | 40.33B | 37.74B | 35.05B | 34.46B | 32.28B | 33.22B |
Total Investments | 2.4B | 3.15B | 2.93B | 2.76B | 2.71B | 2.43B | 2.2B | 1.61B |